143 related articles for article (PubMed ID: 37736812)
1. Clinical data, survival, and prognosis of 426 cases of oropharyngeal cancer: a retrospective analysis.
Li J; Zhuo F; Wang X; Guo Y; Jiang L
Clin Oral Investig; 2023 Nov; 27(11):6597-6606. PubMed ID: 37736812
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract][Full Text] [Related]
4. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
5. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
7. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
10. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
[TBL] [Abstract][Full Text] [Related]
13. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
15. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
[TBL] [Abstract][Full Text] [Related]
17. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of basaloid differentiation in oropharyngeal cancer.
Cooper T; Biron V; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Dec; 42(1):57. PubMed ID: 24350944
[TBL] [Abstract][Full Text] [Related]
19. Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis.
Fujita Y; Fukuda Y; Sanuki F; Irei I; Monobe Y; Uno M; Akisada T; Shimoya K; Hara H; Moriya T
Head Neck Pathol; 2023 Sep; 17(3):658-672. PubMed ID: 37486532
[TBL] [Abstract][Full Text] [Related]
20. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
